Snail and slug mediate tamoxifen resistance in breast cancer cells through activation of EGFR-ERK independent of epithelial-mesenchymal transition

Journal of Molecular Cell Biology

Volumn 6, Issue 4, 2014, Pages 352-354

  Jiang, Yan ^a   Zhao, Xiaotong ^a   Xiao, Qian ^a   Liu, Qingbo ^a   Ding, Keshuo ^b   Yu, Fei ^a   Zhang, Rui ^a   Zhu, Tao ^b   Ge, Gaoxiang ^a,c  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c SHANGHAI XUHUI CENTRAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; MICRORNA 375; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; TAMOXIFEN; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; EGFR PROTEIN, HUMAN; MAPK1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

BREAST CANCER; BREAST CANCER CELL LINE; CANCER GROWTH; CANCER MORTALITY; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; LETTER; MCF 7 CELL LINE; BREAST TUMOR; DRUG RESISTANCE; FEMALE; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; RECEPTOR, EPIDERMAL GROWTH FACTOR; TAMOXIFEN; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 84905160364     PISSN: 16742788     EISSN: 17594685     Source Type: Journal    
DOI: 10.1093/jmcb/mju019     Document Type: Letter

References (9)

1. Coser, K.R., Wittner, B.S., Rosenthal, N.F., et al. (2009). Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common monoclonal drug-resistant progenitor. Proc. Natl Acad. Sci. USA 106, 14536-14541.
2. Hiscox, S., Jiang, W.G., Obermeier, K., et al. (2006). Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation. Int. J. Cancer 118, 290-301.
3. Iseri, O.D., Kars, M.D., Arpaci, F., et al. (2011). Drug resistantMCF-7cellsexhibitepithelial-mesenchymal transition gene expression pattern. Biomed. Pharmacother. 65, 40-45.
4. Kim, M.R., Choi, H.K., Cho, K.B., et al. (2009). Involvement of Pin1 induction in epithelialmesenchymal transition of tamoxifen-resistant breast cancer cells. Cancer Sci. 100, 1834-1841.
5. McBryan, J., Theissen, S.M., Byrne, C., et al. (2012). Metastatic progression with resistance to aromatase inhibitors is driven by the steroid receptor coactivator SRC-1. Cancer Res. 72, 548-559.
6. Musgrove, E.A., and Sutherland, R.L. (2009). Biological determinants of endocrine resistance in breast cancer. Nat. Rev. Cancer 9, 631-643.
7. Vesuna, F., Lisok, A., Kimble, B., et al. (2011). Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptoralpha. Oncogene 31, 3223-3234.
8. Ward, A., Balwierz, A., Zhang, J.D., et al. (2012). Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer. Oncogene 32, 1173-1182.
9. Zhou, C., Zhong, Q., Rhodes, L.V., et al. (2012). Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration. Breast Cancer Res. 14, R45.